Advanced EGFR-mutant NCSLC resistant to osimertinib therapy as a result of a novel CGN-RET fusion mutation with favorable response to combined osimertinib and selpercaptinib, case report

Hamid Mirshahidi; Sue Min Sophia Kwon; Alberto Romagnolo; Kiwon Park; Adam Hagele

doi:10.1016/j.cpccr.2023.100246

Advanced EGFR-mutant NCSLC resistant to osimertinib therapy as a result of a novel CGN-RET fusion mutation with favorable response to combined osimertinib and selpercaptinib, case report

Hamid Mirshahidi, Sue Min Sophia Kwon, Alberto Romagnolo, Kiwon Park, Adam Hagele

Hematology/Oncology Division

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	100246
Journal	Current Problems in Cancer: Case Reports
Volume	11
DOIs	https://doi.org/10.1016/j.cpccr.2023.100246
State	Published - Sep 2023

ASJC Scopus Subject Areas

Oncology

Keywords

Case report
EGFR-mutant
NSCLC
RET-mutant

Access to Document

10.1016/j.cpccr.2023.100246

OpenUrl availability

Full text

Cite this

Mirshahidi, H., Kwon, S. M. S., Romagnolo, A., Park, K., & Hagele, A. (2023). Advanced EGFR-mutant NCSLC resistant to osimertinib therapy as a result of a novel CGN-RET fusion mutation with favorable response to combined osimertinib and selpercaptinib, case report. Current Problems in Cancer: Case Reports, 11, Article 100246. https://doi.org/10.1016/j.cpccr.2023.100246

Advanced EGFR-mutant NCSLC resistant to osimertinib therapy as a result of a novel CGN-RET fusion mutation with favorable response to combined osimertinib and selpercaptinib, case report. / Mirshahidi, Hamid; Kwon, Sue Min Sophia; Romagnolo, Alberto et al.
In: Current Problems in Cancer: Case Reports, Vol. 11, 100246, 09.2023.

Research output: Contribution to journal › Article › peer-review

@article{7b720a83d56c4f319824ed5c7c428dd4,

title = "Advanced EGFR-mutant NCSLC resistant to osimertinib therapy as a result of a novel CGN-RET fusion mutation with favorable response to combined osimertinib and selpercaptinib, case report",

keywords = "Case report, EGFR-mutant, NSCLC, RET-mutant",

author = "Hamid Mirshahidi and Kwon, {Sue Min Sophia} and Alberto Romagnolo and Kiwon Park and Adam Hagele",

note = "Publisher Copyright: {\textcopyright} 2023",

year = "2023",

month = sep,

doi = "10.1016/j.cpccr.2023.100246",

language = "English",

volume = "11",

journal = "Current Problems in Cancer: Case Reports",

issn = "2666-6219",

}

TY - JOUR

T1 - Advanced EGFR-mutant NCSLC resistant to osimertinib therapy as a result of a novel CGN-RET fusion mutation with favorable response to combined osimertinib and selpercaptinib, case report

AU - Mirshahidi, Hamid

AU - Kwon, Sue Min Sophia

AU - Romagnolo, Alberto

AU - Park, Kiwon

AU - Hagele, Adam

PY - 2023/9

Y1 - 2023/9

KW - Case report

KW - EGFR-mutant

KW - NSCLC

KW - RET-mutant

UR - http://www.scopus.com/inward/record.url?scp=85159845558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85159845558&partnerID=8YFLogxK

U2 - 10.1016/j.cpccr.2023.100246

DO - 10.1016/j.cpccr.2023.100246

M3 - Article

AN - SCOPUS:85159845558

SN - 2666-6219

VL - 11

JO - Current Problems in Cancer: Case Reports

JF - Current Problems in Cancer: Case Reports

M1 - 100246

ER -

Advanced EGFR-mutant NCSLC resistant to osimertinib therapy as a result of a novel CGN-RET fusion mutation with favorable response to combined osimertinib and selpercaptinib, case report

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this